Results 101 to 110 of about 31,323 (271)

Characterizing driving behavior using automatic visual analysis

open access: yes, 2014
In this work, we present the problem of rash driving detection algorithm using a single wide angle camera sensor, particularly useful in the Indian context.
Haloi, Mrinal, Jayagopi, Dinesh Babu
core   +1 more source

A phase 3, randomized clinical trial of soticlestat as adjunctive therapy for Lennox–Gastaut syndrome

open access: yesEpilepsia, EarlyView.
Soticlestat as adjunctive therapy for Lennox–Gastaut syndrome. Abstract Objective There remains a need for new treatments for Lennox–Gastaut syndrome (LGS), a developmental and epileptic encephalopathy with a heterogenous patient population that often requires polytherapy. The phase 3, randomized SKYWAY study (NCT04938427) investigated the efficacy and
Renzo Guerrini   +15 more
wiley   +1 more source

Estimation of Driver Drowsiness Using Blood Perfusion Analysis of Facial Thermal Images in a Driving Simulator

open access: yesJournal of Sleep Sciences, 2019
Background and Objective: Driver drowsiness is a major cause of fatal driving accidents worldwide, which can be prevented by an early detection. Driver drowsiness results in reduction of blood flow and change in facial thermal patterns.
Masoumeh Tashakori   +4 more
doaj  

Detection of Drowsiness in Drivers Using Image Processing and Support Vector Machine (SVM) Classification

open access: yesJOIN: Jurnal Online Informatika
Accidents can be caused by external factors on the road, vehicle conditions, or internal factors such as drowsiness. Drowsiness while driving poses risks to the driver and others.
Sugeng, Hendri Praminiarto
doaj   +1 more source

Fenfluramine in SCN1A‐related GEFS+: A multicenter observational study on efficacy, EEG improvement, and tolerability

open access: yesEpilepsia Open, EarlyView.
Abstract The SCN1A gene is implicated in a broad spectrum of epilepsy phenotypes, ranging from self‐limited genetic epilepsy with febrile seizures plus (GEFS+) to severe developmental and epileptic encephalopathies such as Dravet syndrome (DS). While fenfluramine (FFA) has demonstrated strong efficacy in DS, its role in SCN1A‐related epilepsies beyond ...
Giovanni B. Dell'Isola   +12 more
wiley   +1 more source

Detecting Driver Drowsiness Using Hybrid Facial Features and Ensemble Learning

open access: yesInformation
Drowsiness while driving poses a significant risk in terms of road safety, making effective drowsiness detection systems essential for the prevention of accidents.
Changbiao Xu   +3 more
doaj   +1 more source

An Improved Fatigue Detection System Based on Behavioral Characteristics of Driver

open access: yes, 2017
In recent years, road accidents have increased significantly. One of the major reasons for these accidents, as reported is driver fatigue. Due to continuous and longtime driving, the driver gets exhausted and drowsy which may lead to an accident ...
Aman, Kanishk   +3 more
core   +1 more source

Sialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Sialidosis type I (ST‐1) is an autosomal‐recessive, very rare, progressive lysosomal storage disorder caused by pathogenic variants in NEU1. It is clinically characterized by progressive ataxia, myoclonic seizures (MS), bilateral tonic–clonic seizures (BTCS), and distinctive ophthalmological findings.
Janina Gburek‐Augustat   +15 more
wiley   +1 more source

Driver Drowsiness Detection Using Matlab

open access: yesInternational Journal of Engineering Applied Sciences and Technology, 2019
When a driver doesn’t get proper rest, they fall asleep while driving and this leads to fatal accidents. This particular issue demands a solution in the form of a system that is capable of detecting drowsiness and to take necessary actions to avoid accidents.The detection is achieved with three main steps, it begins with face detection and facial ...
openaire   +2 more sources

Practical consensus recommendations for polytherapy involving stiripentol in Dravet syndrome: A nominal group approach

open access: yesEpilepsia Open, EarlyView.
Abstract Objectives Dravet syndrome (DS) is a drug‐resistant developmental and epileptic encephalopathy, often requiring three or more antiseizure medications (ASMs). Consequently, the therapeutic landscape is highly complex, combining DS‐specific agents (stiripentol, STP; cannabidiol, CBD; fenfluramine, FFA), non‐specific ASMs, and non‐pharmacologic ...
J. Helen Cross   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy